Jerusalem, Israel: The administration of the non-psychotropic cannabinoid cannabidiol (CBD) leads to improvement in bone fracture healing, according to preclinical data published online ahead of print in the Journal of Bone and Mineral Research.
Investigators at the Hebrew University Bone Laboratory assessed the ability of CBD administration to promote healing in rats with mid-femoral fractures. Researchers reported, "CBD markedly enhanced the biomechanical properties of the healing femora after 8 weeks."
Authors also evaluated the administration of THC and CBD together, but reported that this combined preparation was "not advantageous" over CBD alone.
They concluded: "CBD alone is sufficiently effective in enhancing fracture healing. ... Multiple experimental and clinical trials have portrayed CBD as a safe agent suggesting further studies in humans to assess its usefulness for improving fracture healing."
Researchers have previously acknowledged that endogenous cannabinoids stimulate bone formation and inhibit bone loss, potentially paving the way for the future use of cannabinoid drugs for combating osteoporosis.
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, "Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing," appears in the Journal of Bone and Mineral Research.